Synthesis and SAR evaluation of oxadiazolopyrazines as selective Haemophilus influenzae antibacterial agents

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 19, 2003, Pages 3133-3136

  Beebe, Xenia ^a   Nilius, Angela M ^a   Merta, Philip J ^a   Soni, Niru B ^a   Bui, Mai H ^a   Wagner, Rolf ^a   Beutel, Bruce A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOACID; ANTIINFECTIVE AGENT; DIAMINOFURAZAN; FURAZAN DERIVATIVE; OXADIAZOLE DERIVATIVE; PHENYL GROUP; PYRAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; HAEMOPHILUS INFLUENZAE; HALOGENATION; NONHUMAN; POLYMERIZATION; STRUCTURE ACTIVITY RELATION;

HAEMOPHILUS; HAEMOPHILUS INFLUENZAE;

EID: 0041831049     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00727-3     Document Type: Article

References (20)

1. (a) Bax R., Mullan N., Verhoef J. Int. J. Antimicrob. Agents. 16:2000;51.
2. (b) Ritter T.K., Wong C.-H. Angew. Chem. Int. Ed. 40:2001;3508.
3. (c) Coates A., Hu Y., Bax R., Page C. Nat. Rev. Drug Discov. 2002;895.
4. (d) Wijkmans J.C.H.M., Beckett R.P. DDT. 7:2002;126.
5. (a) Tong, Y.C. US 3850929, Nov. 26, 1974.
6. (b) Clark, M. T.; Gilmore, I. J. GB 2122492, Jan 18, 1984.
7. (c) Camilleri P., Odell B., O'Neill P. J. Chem. Soc., Perkin Trans. 2. 1987;1671.
8. (a) Gasco A., Rua G., Menziani E., Nano G.M., Tappi G. J. Heterocyclic Chem. 6:1969;769.
9. (b) Sato N., Adachi J. J. Org. Chem. 43:1978;341.
10. (a) Gunasekaran A., Jayachandran T., Boyer J.H., Trudell M.L. J. Heterocyclic Chem. 32:1995;1405.
11. (b) Zelenin A., Trudell M.L. J. Heterocyclic Chem. 34:1997;1057.
12. 3OD) δ 122.9, 130.3, 130.9, 134.2, 136.0, 137.5, 146.8, 150.4, 156.2, 163.5; MS (ESI-) m/z 292/294 1:1 ratio isotopes.
13. (a) Pirrung M.C., Tepper R.J. J. Org. Chem. 60:1995;2461.
14. (b) Taylor M.J., Hoffman T.Z., Yli-Kauhaluoma J.T., Lerner R.A., Janda K.D. J. Am. Chem. Soc. 120:1998;12783.
15. Sheldrake P.W., Suckling K.E., Woodhouse R.N., Murtagh A.J., Herbert R.B., Barker A.C., Stauton J., Battersby A.R. J. Chem. Soc., Perkin Trans. 1. 1998;3003.
16. 6) δ 101.5, 107.5, 109.4, 126.3, 127.9, 145.2, 146.9, 148.8, 150.7, 154.5, 161.2; MS (ESI-) m/z 257 (M-H).
17. Samples were purified by preparative HPLC on a Waters Symmetry C8 column (40×100 mm, 7 μm particle size) using a gradient of 10% to 100% acetonitrile/0.1% aqueous TFA over 12 min (15-min run time) at a flow rate of 70 mL/min.
18. National Committee for Clinical Laboratory Standards. 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A5. National Committee for Clinical Laboratory Standards: Wayne, PA.
19. National Committee for Clinical Laboratory Standards. 2002. Reference Method for Broth Dilution Antifungal Susceptibility Testing. Approved Standard M27-A2. National Committee for Clinical Laboratory Standards: Wayne, PA.
20. 50 value of each compound was calculated, and compared to a database of over 10, 000 compounds, including commercial antibiotics of every structural class available.